Stock Earnings
A Guide To The Risks Of Investing In Altimmune Inc (ALT)
Altimmune Inc’s filing revealed that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17 ’25.
Menu
Altimmune Inc’s filing revealed that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17 ’25.
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Altimmune Inc revealed its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent